107 related articles for article (PubMed ID: 17169375)
21. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
[TBL] [Abstract][Full Text] [Related]
22. Elevated Fas expression is related to increased apoptosis of circulating CD8+ T cell in patients with gastric cancer.
Yoshikawa T; Saito H; Osaki T; Matsumoto S; Tsujitani S; Ikeguchi M
J Surg Res; 2008 Aug; 148(2):143-51. PubMed ID: 18561948
[TBL] [Abstract][Full Text] [Related]
23. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease.
Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Cammarota G; Mirabella M; Attilio Tonali P; Batocchi AP
Hum Immunol; 2008 Dec; 69(12):837-9. PubMed ID: 18940217
[TBL] [Abstract][Full Text] [Related]
25. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
Ysrraelit MC; Gaitán MI; Lopez AS; Correale J
Neurology; 2008 Dec; 71(24):1948-54. PubMed ID: 19064876
[TBL] [Abstract][Full Text] [Related]
26. Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.
Tongiorgi E; Sartori A; Baj G; Bratina A; Di Cola F; Zorzon M; Pizzolato G
J Neurol Sci; 2012 Sep; 320(1-2):161-5. PubMed ID: 22836016
[TBL] [Abstract][Full Text] [Related]
27. Increase in soluble CD95L during subacute phases after human spinal cord injury: a potential therapeutic target.
Biglari B; Büchler A; Swing T; Biehl E; Roth HJ; Bruckner T; Schmidmaier G; Ferbert T; Gerner HJ; Moghaddam A
Spinal Cord; 2013 Mar; 51(3):183-7. PubMed ID: 23184030
[TBL] [Abstract][Full Text] [Related]
28. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
Myśliwiec J; Okota M; Nikołajuk A; Górska M
Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290
[TBL] [Abstract][Full Text] [Related]
29. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
Hamamcioglu K; Reder AT
Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
[TBL] [Abstract][Full Text] [Related]
30. Soluble forms of CD95 and CD95 ligand after living related liver transplantation.
Seino K; Kayagaki N; Yamaguchi N; Takada Y; Uyama S; Kiuchi T; Tanaka K; Yagita H; Okumura K; Fukao K
Transplantation; 1999 Feb; 67(4):634-6. PubMed ID: 10071041
[TBL] [Abstract][Full Text] [Related]
31. Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis.
Zipp F; Otzelberger K; Dichgans J; Martin R; Weller M
J Neuroimmunol; 1998 Jun; 86(2):151-4. PubMed ID: 9663560
[TBL] [Abstract][Full Text] [Related]
32. Increased CD8+ central memory T cells in patients with multiple sclerosis.
Liu GZ; Fang LB; Hjelmström P; Gao XG
Mult Scler; 2007 Mar; 13(2):149-55. PubMed ID: 17439879
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
34. [Detection of the soluble form of the Fas molecule in patients with multiple sclerosis].
Zhou WB; Hans L
Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):39-41. PubMed ID: 12212243
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis-related molecules in blood in multiple sclerosis.
Rinta S; Kuusisto H; Raunio M; Paalavuo R; Levula M; Lehtimäki T; Elovaara I
J Neuroimmunol; 2008 Dec; 205(1-2):135-41. PubMed ID: 18963025
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum soluble Fas ligand is a promising marker of testicular toxicity induced by epirubicin in rats.
Geng J; Fan J; Jiang HW; Fang ZJ; Wang X; Sun JL; Ding Q; Chen G
Toxicol Lett; 2009 Apr; 186(2):96-103. PubMed ID: 19429229
[TBL] [Abstract][Full Text] [Related]
37. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.
Azoulay D; Urshansky N; Karni A
J Neuroimmunol; 2008 Mar; 195(1-2):186-93. PubMed ID: 18329726
[TBL] [Abstract][Full Text] [Related]
38. Analysis of apoptotic markers Fas/FasL (CD95/CD95L) expression on the lymphocytes in patients with acute coronary syndrome.
Bossowska A; Bossowski A; Galar B
Kardiol Pol; 2007 Aug; 65(8):883-9; discussion 890-2. PubMed ID: 17853317
[TBL] [Abstract][Full Text] [Related]
39. Short communication: impairment of membrane markers on peripheral blood mononuclear cells and imbalance of cytokine secretion in the pathogenesis of multiple sclerosis active phases.
Sofo V; Salmeri FM; Di Bella P; Sessa E; D'Aleo G; Trimarchi G; Bramanti P
J Interferon Cytokine Res; 2005 Nov; 25(11):661-5. PubMed ID: 16318579
[TBL] [Abstract][Full Text] [Related]
40. Pregnancy and multiple sclerosis.
Houtchens MK
Semin Neurol; 2007 Nov; 27(5):434-41. PubMed ID: 17940922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
